|
Cancer InformationChemotherapy Drugs: Little best-known side effect YOU need to cognize about!
by:
James Arond-Thomas, MD
In January, 2005 it was reportable that cancer has surpassed heart malady – for the 1st time – as the top killer of Americans younger than 85. In 2002, the most recent year for which information is available, 476,009 Americans younger than 85 died of cancer, compared with 450,637 who died of heart disease. An calculable
1,372,910 new cancer cases and 570,260 cancer deaths are expected this year.
Paclitaxel, a preferred treatment for respiratory organ
and breast cancers, has a cancer-promoting risk as well….
Lung cancer remains the biggest cancer killer, projected to claim 163,510 lives this year. Paclitaxel wish be used in the attempt to save the lives of many a of these patients. However, one little-known effect of Paclitaxel is that in a set
of these patients there wish be up to a multiple
increase in the creation of Lymphokine
– 8 (IL-8) – a cellular communication molecule that initiates the growth of new blood vessels to feed the growing cancer. In different words, if you fall into this set
of patients, treatment mistreatment Paclitaxel alone may not be effective at preventing recurrence.
NF-kB blockade enhances cancer killing ability of Paclitaxel!
IL-8 is under the control of an inflammatory control
supermolecule
called nuclear factor-kappa Beta (NF-kB). Once
the activation of NF-kB is blocked, IL-8 dries up, more like a regulator
that has been turned off. Thus, interference NF-kB activation enhances the cancer killing ability of Paclitaxel. These results were seen with many a types of cancer cells, including respiratory organ
and muscle system cancer cells.
Paclitaxel is NOT the Only Drug that Promotes Excessive NF-kB
Paclitaxel is but one of a group of drugs that has this unwanted side-effect of activating NF-kB. Different drugs in this group include Doxorubicin, 5-Fluorouracil, Cisplatin, VP-16 (Etoposide), ARA-C, and Methotrexate. In addition, research demonstrates that excessive NF-kB activity contributes to cancer development in the following types of cancers: non-small cell respiratory organ
cancer, pancreatic, primary liver, head and neck cancer, prostate, breast, esophageal, stomach, colon, Hodgkin’s disease, and multiple myeloma.
Supportive treatment that improves therapy
effectiveness…..
Paclitaxel, on
with the different NF-kB activating therapy drugs, is authorised for the treatment of a wide range of cancers. It appears likely that they wish continue to be used for the predictable
future. If you are on (or considering using) Paclitaxel or one of the different drugs in this group to treat cancer, there is a adjunct treatment that you need to cognize just about that improves the effectiveness of these drugs and reduces your risk of having a cancer recurrence.
We have a Multi-Dimensional Approach to Reducing Inflammation that Complements and Enhances the Impact of these Drugs!
At the Center for Learning just about Healing in Ann Arbor, MI wherever
I practice integrative medicine and behavioral oncology, I focus on multi-dimensional route to empower patients to appraise and change patterns of eating, behaving, thinking, and brick that are best-known to contribute to inflammatory reactions in the body. These methods complement the cancer killing effects of Paclitaxel, Doxorubicin, 5-FU, and different such drugs.
Genomic Testing Can Clarify Your Specific Inflammatory Building block
Mechanisms that Sustain Your Cancer
Inflammation is present before, and during the life of a cancer. In cancer, inflammation is a pathological process defined
by injury or destruction of tissues caused by a variety of cellular and chemical reactions. It is commonly manifested by typical signs of pain, heat, redness, swelling, and loss of function. However, inflammation is as well essential for tissue repair and tissue rebuilding. Genomic testing (easily performed with secretion or blood samples) allows us to create a personalized map of your inflammatory tendencies based on your genomic predispositions. This know-how
is revolutionary because it allows you to regulate your genomic capabilities to your advantage, which then allows you to reduce the expression of your inflammation-related genes.
What Cancer Patients Need to DO is
Reduce the Expression of Inflammation-Related Genes
Once you cognize your specific genomic blueprint for excessive inflammation, we activity together to develop the tools you need to re-set the expression of your inflammation blueprint. These tools must be unique to you, precisely because your genomic expression capabilities are unique to you. These tools include anti-inflammatory diets supported by oral and blood vessel
nutrients that block and down-regulate NF-kB. Remember, it is this supermolecule
that is responsible for the abnormal rise in IL-8 during Paclitaxel administration. By activity markers of cellular inflammation before, during, and after therapy
treatment, and mistreatment your unique tools, we compile a personalized treatment record of inflammatory responses (normal and abnormal) that serves as a benchmark for your risk of cancer repeat after therapy
treatment.
With these personalized guidelines, you wish have business executive
noesis just about choices of foods, behaviors, and social
relationships that wish be causative to keeping your inflammation-related genes quiet. Patients with high inflammatory markers during therapy
are at higher risk for recurrence, and thus need to more closely monitor and modulate their NF-kB expression after the therapy
ends.
What is important to understand is that:
- There is an best
figure of expression of NF-kB consistent with health;
- Excessive expression contributes to diseases like cancer recurrence, especially once
NF-kB is turned on continuously; and
- You wish have the power and the tools necessary to regulate NF-kB’s expression.
Become the Captain of Your Healing Team!
As your physician-coach, I recommend that you become the captain of your healing team, and let me and my team partner with you to clarify the specific building block
mechanisms drive your specific cancer. We coach you to discover the skills and to master the tools necessary to reduce the collective contribution of foods, emotions, and behaviors to the excessive expression of inflammation-related genes. By working together, you discover to modulate your inflammation blueprint by modulating the communicatory
capacity of NF-kB. Modulating your expression of NF-kB is the inner game of self-discovery, consciousness expansion, forgiveness, and cell (self) renewal that is what allows healing to occur. (To view diagrams describing NF-kB in health and in disease, visit our website at http://www.arond-thomasonline.com!)
Learn Much just about How You Can Improve Your Chances of Not Having a Cancer Recurrence…
You or a adored one can discover more just about how you can improve the effectiveness of your cancer treatments and improve your chances of not having a recurrence. at http://www.1CancerCoach.com.
Just just about the author:
James Arond-Thomas, MD, is Director of The Center for Learning just about Healing in Ann Arbor and West Bloomfield, MI. Dr. Arond-Thomas partners with folk with cancers and different serious illnesses to construct a "whole person" roadmap leading to health and well-being. To find out more just about how you can benefit from Dr. James' ground-breaking research and clinical experience, send an email to DrJames@1CancerCoach.com, or call us at (734) 995.4999.
Circulated by Article Emporium
| |
